Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ampullary Adenocarcinoma × Leucovorin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 195 Rectal Neoplasms 98 Colonic Neoplasms 85 Pancreatic Neoplasms 81 Stomach Neoplasms 71 Neoplasm Metastasis 55 Esophageal Neoplasms 37 Carcinoma, Hepatocellular 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Neoplasms 22 Adenocarcinoma Of Esophagus 22 Lymphoma 21 Adenocarcinoma 18 Leukemia 16 Biliary Tract Neoplasms 15 Cholangiocarcinoma 13 Gastrointestinal Neoplasms 12 Burkitt Lymphoma 12 Lymphoma, Non-Hodgkin 9 Liver Neoplasms 9 Gallbladder Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Osteosarcoma 8 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Bile Duct Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Peritoneal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Mantle-Cell 6

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡